Publicaciones en las que colabora con Tobias Engel (15)

2023

  1. P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

2022

  1. Purinergic Signalling and Inflammation-Related Diseases

    Cells

2021

  1. Editorial: P2X7 as Common Therapeutic Target in Brain Diseases

    Frontiers in Molecular Neuroscience

2018

  1. Haploinsufficient TNAP mice display decreased extracellular ATP levels and expression of Pannexin-1 channels

    Frontiers in Pharmacology, Vol. 9, Núm. MAR

  2. MicroRNA-22 controls aberrant neurogenesis and changes in neuronal morphology after status epilepticus

    Frontiers in Molecular Neuroscience, Vol. 11

2017

  1. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy

    Epilepsia, Vol. 58, Núm. 9, pp. 1603-1614

2016

  1. Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation

    Human Molecular Genetics, Vol. 25, Núm. 19, pp. 4143-4156

  2. Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy

    Journal of Neuroscience, Vol. 36, Núm. 22, pp. 5920-5932

2015

  1. MicroRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus

    Scientific Reports, Vol. 5

2014

  1. P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage

    CNS Neuroscience and Therapeutics, Vol. 20, Núm. 6, pp. 556-564

2013

  1. Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079

    Epilepsia, Vol. 54, Núm. 9, pp. 1551-1561

  2. P2X receptors as targets for the treatment of status epilepticus

    Frontiers in Cellular Neuroscience, Vol. 7, Núm. NOV

2012

  1. Looking for novel functions of tau

    Biochemical Society Transactions

  2. P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control

    International Journal of Physiology, Pathophysiology and Pharmacology, Vol. 4, Núm. 4, pp. 174-187

  3. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice

    FASEB Journal, Vol. 26, Núm. 4, pp. 1616-1628